nei THIS MONTH IN
PSYCHOPHARMACOLOGY
Browsing articles in "Child Psychiatry"

 

FDA Approves First Cannabis-Derived Medication Approved
July 3, 2018   

The US Food and Drug Administration (FDA) has approved the first cannabis-based medicine to treat drug resistant childhood epilepsies...
 Continue reading (Members only)
2018 APA Highlight: Self-Harm and Suicide Death Among Adolescents and Young Adults
May 7, 2018   

During the 2018 American Psychiatric Association (APA) Annual Meeting, experts discussed the current state treatment-resistant depression (TRD) in adolescents and suicidality from different perspectives...
 Continue reading
FDA Advisory Committee Unanimously Supports Approval of Cannabidiol Formulation for Severe Epilepsy
May 1, 2018   

A US FDA Advisory Committee has unanimously voted to support the approval of a plant-based cannabidiol formulation for the adjunct treatment of seizures associated with two severe forms of epilepsy...
 Continue reading
Autism Awareness: Review of Pharmacotherapy for Emotional/Behavioral Symptoms and Potential Future Targets
March 20, 2018   

Autism spectrum disorder (ASD) is a neurodevelopmental disorder typically diagnosed in childhood and characterized by persistent deficits in social communication and interaction and restricted, repetitive patterns of behavior, interests, and activities. There are no pharmacological agents approved...
 Continue reading
FDA Approves Lurasidone for Pediatric Bipolar Depression
March 8, 2018   

The US Food and Drug Administration (FDA) has approved lurasidone for the treatment of bipolar depression in pediatric patients (ages 10 to 17)...
 Continue reading
UPDATE: New Guidelines Published for Diagnosis and Treatment of Depression in Adolescents in Primary Care
March 7, 2018   

Depression in children and adolescence is an enormous issue, especially given the potential risk for suicide in this young patient population. Unfortunately, in the primary care setting (which is where many patients are initially or solely seen by clinicians) as many as 2/3 of pediatric patients with depressive symptoms are not diagnosed...
 Continue reading
NIH Releases First Dataset from ABCD Study on Adolescent Brain Development
March 3, 2018   

The National Institutes of Health (NIH) released the first data from 4,500 participants in the Adolescent Brain Cognitive Development (ABCD) study....
 Continue reading (Members only)
Drinking in Adolescence May Alter Brain Development
November 20, 2017   

A recent study found initiating drinking during adolescence was associated with disordered normal brain growth trajectories....
 Continue reading
Increased Risk of Type 2 Diabetes in Pediatric Patients Taking Antidepressants
November 1, 2017   

A newly published study found there an increased risk for youths to develop type 2 diabetes with current use of antidepressants. The antidepressant subclass, duration of antidepressant use, cumulative antidepressant dose, and average daily dose were...
 Continue reading
Relative Age Within the School Year Affects Diagnosis of ADHD in Younger Children
October 27, 2017   

In a large study using population-based registry data, researchers found that younger age within the school year is associated with a higher likelihood of receiving a diagnosis of attention deficit hyperactivity disorder (ADHD)...
 Continue reading
1234
Top of Page